Literature DB >> 21932773

The GRP1 PH domain, like the AKT1 PH domain, possesses a sentry glutamate residue essential for specific targeting to plasma membrane PI(3,4,5)P(3).

Carissa Pilling1, Kyle E Landgraf, Joseph J Falke.   

Abstract

During the appearance of the signaling lipid PI(3,4,5)P(3), an important subset of pleckstrin homology (PH) domains target signaling proteins to the plasma membrane. To ensure proper pathway regulation, such PI(3,4,5)P(3)-specific PH domains must exclude the more prevalant, constitutive plasma membrane lipid PI(4,5)P(2) and bind the rare PI(3,4,5)P(3) target lipid with sufficiently high affinity. Our previous study of the E17K mutant of the protein kinase B (AKT1) PH domain, together with evidence from Carpten et al. [Carpten, J. D., et al. (2007) Nature 448, 439-444], revealed that the native AKT1 E17 residue serves as a sentry glutamate that excludes PI(4,5)P(2), thereby playing an essential role in specific PI(3,4,5)P(3) targeting [Landgraf, K. E., et al. (2008) Biochemistry 47, 12260-12269]. The sentry glutamate hypothesis proposes that an analogous sentry glutamate residue is a widespread feature of PI(3,4,5)P(3)-specific PH domains, and that charge reversal mutation at the sentry glutamate position will yield both increased PI(4,5)P(2) affinity and constitutive plasma membrane targeting. To test this hypothesis, we investigated the E345 residue, a putative sentry glutamate, of the general receptor for phosphoinositides 1 (GRP1) PH domain. The results show that incorporation of the E345K charge reversal mutation into the GRP1 PH domain enhances PI(4,5)P(2) affinity 8-fold and yields constitutive plasma membrane targeting in cells, reminiscent of the effects of the E17K mutation in the AKT1 PH domain. Hydrolysis of plasma membrane PI(4,5)P(2) releases the E345K GRP1 PH domain into the cytoplasm, and the efficiency of this release increases when Arf6 binding is disrupted. Overall, the findings provide strong support for the sentry glutamate hypothesis and suggest that the GRP1 E345K mutation will be linked to changes in cell physiology and human pathologies, as demonstrated for AKT1 E17K [Carpten, J. D., et al. (2007) Nature 448, 439-444; Lindhurst, M. J., et al. (2011) N. Engl. J. Med. 365, 611-619]. Analysis of available PH domain structures suggests that a lone glutamate residue (or, in some cases, an aspartate) is a common, perhaps ubiquitous, feature of PI(3,4,5)P(3)-specific binding pockets that functions to lower PI(4,5)P(2) affinity.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21932773      PMCID: PMC3217903          DOI: 10.1021/bi2011306

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  45 in total

1.  Structure of the PH domain from Bruton's tyrosine kinase in complex with inositol 1,3,4,5-tetrakisphosphate.

Authors:  E Baraldi; K Djinovic Carugo; M Hyvönen; P L Surdo; A M Riley; B V Potter; R O'Brien; J E Ladbury; M Saraste
Journal:  Structure       Date:  1999-04-15       Impact factor: 5.006

Review 2.  Exploiting the PI3K/AKT pathway for cancer drug discovery.

Authors:  Bryan T Hennessy; Debra L Smith; Prahlad T Ram; Yiling Lu; Gordon B Mills
Journal:  Nat Rev Drug Discov       Date:  2005-12       Impact factor: 84.694

Review 3.  Membrane binding domains.

Authors:  James H Hurley
Journal:  Biochim Biophys Acta       Date:  2006-03-24

4.  3-D structure and dynamics of protein kinase B-new mechanism for the allosteric regulation of an AGC kinase.

Authors:  Véronique Calleja; Michel Laguerre; Banafshé Larijani
Journal:  J Chem Biol       Date:  2009-02-20

5.  Phosphorylation-independent dual-site binding of the FHA domain of KIF13 mediates phosphoinositide transport via centaurin alpha1.

Authors:  Yufeng Tong; Wolfram Tempel; Hui Wang; Kaori Yamada; Limin Shen; Guillermo A Senisterra; Farrell MacKenzie; Athar H Chishti; Hee-Won Park
Journal:  Proc Natl Acad Sci U S A       Date:  2010-11-05       Impact factor: 11.205

Review 6.  Cytohesins and centaurins: mediators of PI 3-kinase-regulated Arf signaling.

Authors:  T R Jackson; B G Kearns; A B Theibert
Journal:  Trends Biochem Sci       Date:  2000-10       Impact factor: 13.807

Review 7.  Synthesis and function of 3-phosphorylated inositol lipids.

Authors:  B Vanhaesebroeck; S J Leevers; K Ahmadi; J Timms; R Katso; P C Driscoll; R Woscholski; P J Parker; M D Waterfield
Journal:  Annu Rev Biochem       Date:  2001       Impact factor: 23.643

8.  Phosphatidylinositol 4,5-bisphosphate-specific AKT1 is oncogenic.

Authors:  Nadine Dannemann; Jonathan Ross Hart; Lynn Ueno; Peter K Vogt
Journal:  Int J Cancer       Date:  2010-07-01       Impact factor: 7.396

9.  Activation of Bruton's tyrosine kinase (BTK) by a point mutation in its pleckstrin homology (PH) domain.

Authors:  T Li; S Tsukada; A Satterthwaite; M H Havlik; H Park; K Takatsu; O N Witte
Journal:  Immunity       Date:  1995-05       Impact factor: 31.745

10.  Single-molecule fluorescence studies of a PH domain: new insights into the membrane docking reaction.

Authors:  Jefferson D Knight; Joseph J Falke
Journal:  Biophys J       Date:  2009-01       Impact factor: 4.033

View more
  17 in total

1.  Lipid targeting domain with dual-membrane specificity that expands the diversity of intracellular targeting reactions.

Authors:  Joseph J Falke
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-26       Impact factor: 11.205

2.  Regulation of insulin signaling by the phosphatidylinositol 3,4,5-triphosphate phosphatase SKIP through the scaffolding function of Pak1.

Authors:  Takeshi Ijuin; Tadaomi Takenawa
Journal:  Mol Cell Biol       Date:  2012-07-02       Impact factor: 4.272

3.  Structural basis for membrane recruitment and allosteric activation of cytohesin family Arf GTPase exchange factors.

Authors:  Andrew W Malaby; Bert van den Berg; David G Lambright
Journal:  Proc Natl Acad Sci U S A       Date:  2013-08-12       Impact factor: 11.205

Review 4.  Interplay between phosphoinositide lipids and calcium signals at the leading edge of chemotaxing ameboid cells.

Authors:  Joseph J Falke; Brian P Ziemba
Journal:  Chem Phys Lipids       Date:  2014-01-19       Impact factor: 3.329

5.  Switch-like activation of Bruton's tyrosine kinase by membrane-mediated dimerization.

Authors:  Jean K Chung; Laura M Nocka; Aubrianna Decker; Qi Wang; Theresa A Kadlecek; Arthur Weiss; John Kuriyan; Jay T Groves
Journal:  Proc Natl Acad Sci U S A       Date:  2019-05-10       Impact factor: 11.205

6.  Molecular mechanism of membrane binding of the GRP1 PH domain.

Authors:  Chun-Liang Lai; Anand Srivastava; Carissa Pilling; Anna R Chase; Joseph J Falke; Gregory A Voth
Journal:  J Mol Biol       Date:  2013-06-06       Impact factor: 5.469

7.  The PH domain of phosphoinositide-dependent kinase-1 exhibits a novel, phospho-regulated monomer-dimer equilibrium with important implications for kinase domain activation: single-molecule and ensemble studies.

Authors:  Brian P Ziemba; Carissa Pilling; Véronique Calleja; Banafshé Larijani; Joseph J Falke
Journal:  Biochemistry       Date:  2013-07-09       Impact factor: 3.162

8.  Association of Peripheral Membrane Proteins with Membranes: Free Energy of Binding of GRP1 PH Domain with Phosphatidylinositol Phosphate-Containing Model Bilayers.

Authors:  Fiona B Naughton; Antreas C Kalli; Mark S P Sansom
Journal:  J Phys Chem Lett       Date:  2016-03-17       Impact factor: 6.475

9.  Cancer associated E17K mutation causes rapid conformational drift in AKT1 pleckstrin homology (PH) domain.

Authors:  Ambuj Kumar; Rituraj Purohit
Journal:  PLoS One       Date:  2013-05-31       Impact factor: 3.240

10.  Membrane docking geometry of GRP1 PH domain bound to a target lipid bilayer: an EPR site-directed spin-labeling and relaxation study.

Authors:  Huai-Chun Chen; Brian P Ziemba; Kyle E Landgraf; John A Corbin; Joseph J Falke
Journal:  PLoS One       Date:  2012-03-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.